source
- Medicare to End Extra Payments for FDA Breakthrough Devices Starting FY2028Medicare announced that it will eliminate the special pathways that have let medical devices labeled as breakthrough by the FDA receive supplemental payments without showing a clear clinical advant…
- Sandoz to Pay $478.5 Million to Settle Generic Drug Price-Fixing ClaimsSandoz has agreed to pay $478.5 million to resolve allegations that it participated in a widespread conspiracy to inflate and manipulate the prices of generic medicines. Dozens of U.S. states and i…